G. Mithieux, F. Rajas, and A. Gautier-stein, A Novel Role for Glucose 6-Phosphatase in the Small Intestine in the Control of Glucose Homeostasis, Journal of Biological Chemistry, vol.279, issue.43, pp.44231-44234, 2004.
DOI : 10.1074/jbc.R400011200

G. Mithieux, I. Bady, and A. Gautier, Induction of control genes in intestinal gluconeogenesis is sequential during fasting and maximal in diabetes, AJP: Endocrinology and Metabolism, vol.286, issue.3, pp.370-375, 2004.
DOI : 10.1152/ajpendo.00299.2003

F. Rajas, H. Jourdan-pineau, and A. Stefanutti, Immunocytochemical localization of glucose 6-phosphatase and cytosolic phosphoenolpyruvate carboxykinase in gluconeogenic tissues reveals unsuspected metabolic zonation, Histochemistry and Cell Biology, vol.38, issue.5, pp.555-565, 2007.
DOI : 10.1007/s00418-006-0263-5

J. Chou, D. Matern, and B. Mansfield, Type I Glycogen Storage Diseases: Disorders of the Glucose-6- Phosphatase Complex, Current Molecular Medicine, vol.2, issue.2, pp.121-143, 2002.
DOI : 10.2174/1566524024605798

J. Wolfsdorf, J. Crigler, and . Jr, Effect of Continuous Glucose Therapy Begun in Infancy on the Long-Term Clinical Course of Patients with Type I Glycogen Storage Disease, Journal of Pediatric Gastroenterology and Nutrition, vol.29, issue.2, pp.136-143, 1999.
DOI : 10.1097/00005176-199908000-00008

D. Weinstein and J. Wolfsdorf, Effect of continuous glucose therapy with uncooked cornstarch on the long-term clinical course of type 1a glycogen storage disease, European Journal of Pediatrics, vol.56, issue.1, pp.35-39, 2002.
DOI : 10.1007/BF02679991

J. Rake, G. Visser, and P. Labrune, Guidelines for management of glycogen storage disease type I???European study on glycogen storage disease type I (ESGSD I), European Journal of Pediatrics, vol.20, issue.Suppl 1, pp.112-119, 2002.
DOI : 10.1007/BF02680007

R. Froissart, M. Piraud, and A. Boudjemline, Glucose-6-phosphatase deficiency, Orphanet Journal of Rare Diseases, vol.6, issue.1, p.27, 2011.
DOI : 10.2174/156652307780363152

URL : https://hal.archives-ouvertes.fr/inserm-00668423

J. Chou, H. Jun, and B. Mansfield, Glycogen storage disease type I and G6Pase-?? deficiency: etiology and therapy, Nature Reviews Endocrinology, vol.51, issue.12, pp.676-688, 2010.
DOI : 10.1038/nrendo.2010.189

Y. Chen, R. Coleman, and J. Scheinman, Renal Disease in Type I Glycogen Storage Disease, New England Journal of Medicine, vol.318, issue.1, pp.7-11, 1988.
DOI : 10.1056/NEJM198801073180102

L. Baker, S. Dahlem, and S. Goldfarb, Hyperfiltration and renal disease in glycogen storage disease, type I, Kidney International, vol.35, issue.6, pp.1345-1350, 1989.
DOI : 10.1038/ki.1989.133

Y. Chen, Type I glycogen storage disease: Kidney involvement, pathogenesis and its treatment, Pediatric Nephrology, vol.313, issue.1, pp.71-76, 1991.
DOI : 10.1007/BF00852851

W. Reitsma-bierens, G. Smit, and J. Troelstra, Renal function and kidney size in glycogen storage disease type I, Pediatric Nephrology, vol.30, issue.3, pp.236-238, 1992.
DOI : 10.1007/BF00878355

W. Reitsma-bierens, Renal complications in glycogen storage disease type I, European Journal of Pediatrics, vol.112, issue.S1, pp.60-62, 1993.
DOI : 10.1007/BF02072091

P. Lee, R. Dalton, and V. Shah, Glomerular and tubular function in glycogen storage disease, Pediatric Nephrology, vol.23, issue.Suppl 1, pp.705-710, 1995.
DOI : 10.1007/BF00868717

W. Yiu, C. Pan, and R. Ruef, Angiotensin mediates renal fibrosis in the nephropathy of glycogen storage disease type Ia, Kidney International, vol.73, issue.6, pp.716-723, 2008.
DOI : 10.1038/sj.ki.5002718

W. Yiu, P. Mead, and H. Jun, Oxidative stress mediates nephropathy in type Ia glycogen storage disease, Laboratory Investigation, vol.15, issue.4, pp.620-629, 2010.
DOI : 10.1111/j.1365-2265.2005.02292.x

D. Melis, G. Parenti, and R. Gatti, Efficacy of ACE-inhibitor therapy on renal disease in glycogen storage disease type 1: a multicentre retrospective study, Clinical Endocrinology, vol.23, issue.1, pp.19-25, 2005.
DOI : 10.1002/jcp.10294

D. Martens, J. Rake, and G. Navis, Renal Function in Glycogen Storage Disease Type I, Natural Course, and Renopreservative Effects of ACE Inhibition, Clinical Journal of the American Society of Nephrology, vol.4, issue.11, pp.1741-1746, 2009.
DOI : 10.2215/CJN.00050109

K. Lei, H. Chen, and C. Pan, Glucose???6???phosphatase dependent substrate transport in the glycogen storage disease type???1a mouse, Nature Genetics, vol.173, issue.2, pp.203-209, 1996.
DOI : 10.1038/ng0696-203

H. Li, X. Zhou, and D. Davis, An androgen-inducible proximal tubule-specific Cre recombinase transgenic model, AJP: Renal Physiology, vol.294, issue.6, pp.1481-1486, 2008.
DOI : 10.1152/ajprenal.00064.2008

R. Carew, B. Wang, and P. Kantharidis, The role of EMT in renal fibrosis, Cell and Tissue Research, vol.97, issue.Suppl 1, pp.103-116, 2012.
DOI : 10.1007/s00441-011-1227-1

M. Urushihara, S. Kagami, and M. Ito, Transforming growth factor-??? in renal disease with glycogen storage disease I, Pediatric Nephrology, vol.19, issue.6, pp.676-678, 2004.
DOI : 10.1007/s00467-004-1456-6

Y. Chen, J. Scheinman, and H. Park, Amelioration of Proximal Renal Tubular Dysfunction in Type I Glycogen Storage Disease with Dietary Therapy, New England Journal of Medicine, vol.323, issue.9, pp.590-593, 1990.
DOI : 10.1056/NEJM199008303230907

N. Matsuo, Y. Tsuchiya, and H. Cho, Proximal Renal Tubular Acidosis in a Child with Type 1 Glycogen Storage Disease, Acta Paediatrica, vol.86, issue.2, pp.332-335, 1986.
DOI : 10.1203/00006450-196711000-00004

D. Weinstein, M. Somers, and J. Wolfsdorf, Decreased urinary citrate excretion in type 1a glycogen storage disease, The Journal of Pediatrics, vol.138, issue.3, pp.378-382, 2001.
DOI : 10.1067/mpd.2001.111322

M. Emmett and R. Narins, Renal tranplantation in type 1 glycogenosis. Failure to improve glucose metabolism, JAMA: The Journal of the American Medical Association, vol.239, issue.16, pp.1642-1644, 1978.
DOI : 10.1001/jama.239.16.1642

L. Faivre, D. Houssin, and J. Valayer, Long-term outcome of liver transplantation in patients with glycogen storage disease type Ia, Journal of Inherited Metabolic Disease, vol.22, issue.6, pp.723-732, 1999.
DOI : 10.1023/A:1005544117285

P. Labrune, Glycogen storage disease type I: indications for liver and/or kidney transplantation, European Journal of Pediatrics, vol.137, issue.Suppl 1, pp.53-55, 2002.
DOI : 10.1007/BF02679995

S. Reddy, S. Austin, and M. Spencer-manzon, Liver transplantation for glycogen storage disease type Ia, Journal of Hepatology, vol.51, issue.3, pp.483-490, 2009.
DOI : 10.1016/j.jhep.2009.05.026

M. Davis and D. Weinstein, Liver transplantation in children with glycogen storage disease: Controversies and evaluation of the risk/benefit of this procedure, Pediatric Transplantation, vol.63, issue.Suppl. 1, pp.137-145, 2008.
DOI : 10.1111/j.1399-3046.2007.00803.x

A. Jankauskiene, V. Druskis, and A. Laurinavicius, Cyclosporine nephrotoxicity: associated allograft dysfunction at low trough concentration, Clin. Nephrol, vol.56, pp.27-29, 2001.

F. Panaro, E. Andorno, and G. Basile, Simultaneous liver-kidney transplantation for glycogen storage disease type IA (von Gierke's disease), Transplantation Proceedings, vol.36, issue.5, pp.1483-1484, 2004.
DOI : 10.1016/j.transproceed.2004.05.070

M. Belingheri, L. Ghio, and A. Sala, Combined liver-kidney transplantation in glycogen storage disease Ia: A case beyond the guidelines, Liver Transplantation, vol.15, issue.5, pp.762-764, 2007.
DOI : 10.1002/lt.21147

W. Yiu, Y. Lee, and W. Peng, Complete Normalization of Hepatic G6PC Deficiency in Murine Glycogen Storage Disease Type Ia Using Gene Therapy, Molecular Therapy, vol.18, issue.6, pp.1076-1084, 2010.
DOI : 10.1038/mt.2010.64

X. Luo, G. Hall, and S. Li, Hepatorenal Correction in Murine Glycogen Storage Disease Type I With a Double-stranded Adeno-associated Virus Vector, Molecular Therapy, vol.19, issue.11, pp.1961-1970, 2011.
DOI : 10.1038/mt.2011.126

A. Ghosh, M. Allamarvdasht, and C. Pan, Long-term correction of murine glycogen storage disease type Ia by recombinant adeno-associated virus-1-mediated gene transfer, Gene Therapy, vol.14, issue.4, pp.321-329, 2006.
DOI : 10.1038/sj.gt.3301068

P. Mundel and S. Shankland, Podocyte Biology and Response to Injury, Journal of the American Society of Nephrology, vol.13, issue.12, pp.3005-3015, 2002.
DOI : 10.1097/01.ASN.0000039661.06947.FD

G. Wolf, S. Chen, and F. Ziyadeh, From the Periphery of the Glomerular Capillary Wall Toward the Center of Disease: Podocyte Injury Comes of Age in Diabetic Nephropathy, Diabetes, vol.54, issue.6, pp.1626-1634, 2005.
DOI : 10.2337/diabetes.54.6.1626

M. Pagtalunan, P. Miller, and S. Jumping-eagle, Podocyte loss and progressive glomerular injury in type II diabetes., Journal of Clinical Investigation, vol.99, issue.2, pp.342-348, 1997.
DOI : 10.1172/JCI119163

D. Vestra, M. Masiero, A. Roiter, and A. , Is Podocyte Injury Relevant in Diabetic Nephropathy?: Studies in Patients With Type 2 Diabetes, Diabetes, vol.52, issue.4, pp.1031-1035, 2003.
DOI : 10.2337/diabetes.52.4.1031

Y. Li, Y. Kang, and C. Dai, Epithelial-to-Mesenchymal Transition Is a Potential Pathway Leading to Podocyte Dysfunction and Proteinuria, The American Journal of Pathology, vol.172, issue.2, pp.299-308, 2008.
DOI : 10.2353/ajpath.2008.070057

Y. Liu, New Insights into Epithelial-Mesenchymal Transition in Kidney Fibrosis, Journal of the American Society of Nephrology, vol.21, issue.2, pp.212-222, 2010.
DOI : 10.1681/ASN.2008121226

C. Hills and P. Squires, The role of TGF-?? and epithelial-to mesenchymal transition in diabetic nephropathy, Cytokine & Growth Factor Reviews, vol.22, pp.131-139, 2011.
DOI : 10.1016/j.cytogfr.2011.06.002

K. Obara, T. Saito, and H. Sato, Renal histology in two adult patients with type I glycogen storage disease, Clin. Nephrol, vol.39, pp.59-64, 1993.

H. Mundy and P. Lee, Glycogenosis type I and diabetes mellitus: a common mechanism for renal dysfunction?, Medical Hypotheses, vol.59, issue.1, pp.110-114, 2002.
DOI : 10.1016/S0306-9877(02)00199-8

D. Koya and G. King, Protein kinase C activation and the development of diabetic complications, Diabetes, vol.47, issue.6, pp.859-866, 1998.
DOI : 10.2337/diabetes.47.6.859

I. Bobulescu, Renal lipid metabolism and lipotoxicity, Current Opinion in Nephrology and Hypertension, vol.19, issue.4, pp.393-402, 2010.
DOI : 10.1097/MNH.0b013e32833aa4ac

L. Sun, N. Halaihel, and W. Zhang, Role of Sterol Regulatory Element-binding Protein 1 in Regulation of Renal Lipid Metabolism and Glomerulosclerosis in Diabetes Mellitus, Journal of Biological Chemistry, vol.277, issue.21, pp.18919-18927, 2002.
DOI : 10.1074/jbc.M110650200

Z. Wang, T. Jiang, and J. Li, Regulation of Renal Lipid Metabolism, Lipid Accumulation, and Glomerulosclerosis in FVBdb/db Mice With Type 2 Diabetes, Diabetes, vol.54, issue.8, pp.2328-2335, 2005.
DOI : 10.2337/diabetes.54.8.2328

D. Zhang, H. Yang, and X. Kong, Proteomics analysis reveals diabetic kidney as a ketogenic organ in type 2 diabetes, AJP: Endocrinology and Metabolism, vol.300, issue.2, pp.287-295, 2011.
DOI : 10.1152/ajpendo.00308.2010

A. Binkiewicz and B. Senior, Decreased ketogenesis in von Gierke's disease (Type I glycogenosis), The Journal of Pediatrics, vol.83, issue.6, pp.973-978, 1973.
DOI : 10.1016/S0022-3476(73)80531-1

F. Delaere, C. Magnan, and G. Mithieux, Hypothalamic integration of portal glucose signals and control of food intake and insulin sensitivity, Diabetes & Metabolism, vol.36, issue.4, pp.257-262, 2010.
DOI : 10.1016/j.diabet.2010.05.001

R. Feil, J. Brocard, and B. Mascrez, Ligand-activated site-specific recombination in mice., Proceedings of the National Academy of Sciences, vol.93, issue.20
DOI : 10.1073/pnas.93.20.10887

A. Nagy, Cre recombinase: The universal reagent for genome tailoring, genesis, vol.22, issue.2, pp.99-109, 2000.
DOI : 10.1002/(SICI)1526-968X(200002)26:2<99::AID-GENE1>3.0.CO;2-B

G. Pfleiderer, Glycogen, pp.59-62
DOI : 10.1016/B978-0-12-395630-9.50012-8

G. Mithieux, N. Daniele, and B. Payrastre, Liver Microsomal Glucose-6-phosphatase Is Competitively Inhibited by the Lipid Products of Phosphatidylinositol 3-Kinase, Journal of Biological Chemistry, vol.273, issue.1, pp.17-19, 1998.
DOI : 10.1074/jbc.273.1.17

N. Daniele, F. Rajas, and B. Payrastre, Phosphatidylinositol 3-Kinase Translocates onto Liver Endoplasmic Reticulum and May Account for the Inhibition of Glucose-6-phosphatase during Refeeding, Journal of Biological Chemistry, vol.274, issue.6, pp.3597-3601, 1999.
DOI : 10.1074/jbc.274.6.3597

B. Pillot, M. Soty, and A. Gautier-stein, Protein Feeding Promotes Redistribution of Endogenous Glucose Production to the Kidney and Potentiates Its Suppression by Insulin, Endocrinology, vol.150, issue.2, pp.616-624, 2009.
DOI : 10.1210/en.2008-0601